Case Investigation

Emergency Epidemic Investigation Data Collections - Expedited Reviews

Appendix 1. CCHF_Case investigation questionnaire

CCRF_Georgia

OMB: 0920-1011

Document [doc]
Download: doc | pdf

Form Approved

OMB No. 0920-1011

Exp. Date 03/31/2017

















Appendix 1: CCHF Case Investigation Questionnaire

CCHF Case Investigation Questionnaire

Name of examiner Date of filling

_______________________ ___/_____/_______


of history record

Hospitalization Y N

Hospital name___________________________________

Date of hospitalization ___/_____/2011


Demographic data

Date of birth Sex

_____/_____/_______ м F

Residence located in:

Rayon:___________ Sub-district:____________

Employed yes no


Occupation ____________________________________________________________________________

Kind of activity __________________________________________________________________________



Risk factors for CCHF (within 2 weeks before developing a fever)

Tick bite Y N

Date of tick bite: _____/_____/______


Livestock activity Y N

Species contacted:________________________________________


Slaughtering livestock Y N

Species contacted:_________________________________________


Butchering/handling raw meat Y N

Type of meat handled(species):_____________________________


Nursing for person with bleeding Y N


Handling ticks with bare hands Y N


Seeking of medical care due to tick bite Y N

Date of seeking of medical care:_____/_____/_______


Medical facility:_______________________________________


Geographic location of tick bite Rayon:________________ Sub-district:_____________________


Number of ticks removed:____

Tick ID # _______ Species:__________________


Clinical data

Date of symptom/illness onset _____/_____/2011 resolved: _____/_____/2011

Fever Y N onset date: _____/_____/2011 resolved: _____/_____/2011

Headache Y N onset date: _____/_____/2011 resolved: _____/_____/2011

Myalgia/muscle ache Y N onset: _____/_____/2011 resolved: _____/_____/2011

Vomiting Y N onset date: _____/_____/2011 resolved: _____/_____/2011

Diarrhea Y N onset date: _____/_____/2011 resolved: _____/_____/2011



Hemorrhagic syndrome Y N

Hemorrhagic rash Y N Date of onset _____/_____/2011 resolved: _____/_____/2011

Rash Location: Head/face Body Arms/Legs

Hemorrhages/bruising Y N Date of onset_____/_____/2011 resolved: _____/_____/2011

Hemorrhage Location: Head/face Body Arms/Legs


Bleeding Y N Date of onset_____/_____/2011 resolved: _____/_____/2011

Bleeding Location: Gastrointestinal Urogenital Nasal Respiratory


Daily body temperature (maximum value) and blood characteristics


Date

(dd.mm)

Тemperature

°C

Thrombocyte count

White blood cell count

Red blood cell

count

Hemoglobin

Alanine Transferase (ALT)

Aspartate Transferase (AST)


















































































































































(Other symptoms/attributes):________________________________________________________________________


Treatment

Ribavirin Y N

Date of treatment start:____/_____/2011

Date of end of treatment: _____/_____/2011г.

Dosage: ______________________________________________________________________________________________________________________________________________________________________________________________

Mode of administration: Oral Y N Intravenous Y N


Immune plasma Y N

Date of treatment start: _____/_____/2011г.

Date of end of treatment: _____/_____/2011г.

Total volume/units given: ____________________________________________________________


Date of discharge from the hospital: _____/_____/2011г.


Diagnosis: ____________________________________________

Suspect Probable Confirmed Negative


Outcome

survived died unknown


If patient died, date of death: ____/_____/2011

Diagnostic Tests Performed


Blood collection #1

Date of blood collection ___/_____/_______


CCHF diagnostic testing

Tests Result

IgM ELISA positive Negative Uncertain

IgG ELISA positive Negative Uncertain

Antigen ELISA positive Negative Uncertain

PCR positive Negative Uncertain


Other relevant test results:­­­­­­­_______________________________


Blood collection #2

Date of blood collection ___/_____/_______


CCHF diagnostic testing

Tests Result

IgM ELISA positive Negative Uncertain

IgG ELISA positive Negative Uncertain

Antigen ELISA positive Negative Uncertain

PCR positive Negative Uncertain


Other relevant test results:­­­­­­­_______________________________


Blood collection #3

Date of blood collection ___/_____/_______


CCHF diagnostic testing

Tests Result

IgM ELISA positive Negative Uncertain

IgG ELISA positive Negative Uncertain

Antigen ELISA positive Negative Uncertain

PCR positive Negative Uncertain

Other relevant test results:­­­­­­­_______________________________


Tissue Collection

Date of Tissue collection: ___/_____/_______

Tissues sampled: Liver Spleen Blood clot Lymph node other:


CCHF diagnostic testing

Tests Result

Antigen ELISA positive Negative Uncertain

PCR positive Negative Uncertain


Other relevant test results:­­­­­­­_______________________________


Tick testing for CCHF

Date of test: ___/_____/_______

Antigen ELISA positive Negative Uncertain

PCR positive Negative Uncertain


Public reporting burden of this collection of information is estimated to average 5 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)


File Typeapplication/msword
File TitleMENINGITIST QES
AuthorComputer
Last Modified ByDKE
File Modified2014-10-03
File Created2011-06-29

© 2024 OMB.report | Privacy Policy